Who
Elizabeth H. Weatherman
Director
Company insider
Files Form 4 as: Director, Royalty Pharma; Director, Insulet; Director, Nevro; Director, Vapotherm; Director, Silk Road Medical; Director, Wright Medical Group; Director, Talon Therapeutics; Director and 10% owner, ev3.
In numbers
- Trades disclosed
- 273
- Buys
- 12
- Sells
- 20
- Bought
- $4.8M
- Sold
- $477.1M
- Companies
- 12
- Companies where not an officer
- 12
- First trade
- 6 Jan 2006
- Last trade
- 5 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 8 Jun 2026 | RPRX Royalty PharmaPharmaceuticals | SEC FORM 4 Code A | —4,545 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | RPRX Royalty PharmaPharmaceuticals | SEC FORM 4 Code A | —4,545 at $0.00 | filing |
| 3 Jun 2026filed 3 Jun 2026 | PODD InsuletMedical Devices | SEC FORM 4 Bought | $497K3,450 at $144.20 | filing |
| 3 Jun 2026filed 3 Jun 2026 | PODD InsuletMedical Devices | SEC FORM 4 Bought | $497K3,450 at $144.20 | filing |
| 20 May 2026filed 21 May 2026 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —1,660 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —1,660 at $0.00 | filing |
| 31 Jul 2025filed 31 Jul 2025 | RPRX Royalty PharmaPharmaceuticals | SEC FORM 4 Code A | —2,752 at $0.00 | filing |
| 31 Jul 2025filed 31 Jul 2025 | RPRX Royalty PharmaPharmaceuticals | SEC FORM 4 Code A | —5,806 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —778 at $0.00 | filing |
| 3 Apr 2025filed 3 Apr 2025 | Nevro | SEC FORM 4 Code D | —86,171 | filing |
| 31 Dec 2024filed 2 Jan 2025 | Nevro | SEC FORM 4 Code A | —5,325 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | Nevro | SEC FORM 4 Code A | —3,544 at $0.00 | filing |
| 20 Sep 2024filed 24 Sep 2024 | Vapothermoption or derivative | SEC FORM 4 Code D | —1,187 at $0.00 | filing |
| 20 Sep 2024filed 24 Sep 2024 | Vapothermoption or derivative | SEC FORM 4 Code D | —1,089 at $0.00 | filing |
| 20 Sep 2024filed 24 Sep 2024 | Vapotherm | SEC FORM 4 Code D | $32K14,555 at $2.18 | filing |
| 20 Sep 2024filed 24 Sep 2024 | Vapotherm | SEC FORM 4 Code D | $6,5403,000 at $2.18 | filing |
| 20 Sep 2024filed 24 Sep 2024 | Vapotherm | SEC FORM 4 Code D | $178K81,546 at $2.18 | filing |
| 17 Sep 2024filed 18 Sep 2024 | Silk Road Medicaloption or derivative | SEC FORM 4 Code D | $911K35,185 at $25.90 | filing |
| 17 Sep 2024filed 18 Sep 2024 | Silk Road Medicaloption or derivative | SEC FORM 4 Code D | $67K8,910 at $7.50 | filing |
| 17 Sep 2024filed 18 Sep 2024 | Silk Road Medical | SEC FORM 4 Code D | —155,004 | filing |
News
No headline names them, or the companies they trade most, lately.